T-cell replete cord transplants give superior outcomes in high-risk and relapsed/refractory pediatric myeloid malignancy

Stem cell transplant (SCT) outcomes in high-risk and relapsed/refractory (R/R) pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) have been historically poor. Cord blood (CB) allows T-cell replete CB transplant (TRCB), enabling enhanced graft-versus-leukemia. We consecutively...

Descripción completa

Detalles Bibliográficos
Autores principales: Horgan, Claire, Mullanfiroze, Khushnuma, Rauthan, Archana, Patrick, Katharine, Butt, Naeem Akram, Mirci-Danicar, Oana, O’Connor, Olya, Furness, Caroline, Deshpande, Akshay, Lawson, Sarah, Broderick, Valerie, Evans, Pamela, Gibson, Brenda, Roberts, Wing, Ali, Salah, Galani, Sevasti, Kirkwood, Amy A., Jovanovic, Jelena, Dillon, Richard, Virgo, Paul, James, Beki, Rao, Kanchan, Amrolia, Persis J., Wynn, Robert F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Hematology 2023
Materias:
Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206437/
https://www.ncbi.nlm.nih.gov/pubmed/36649566
http://dx.doi.org/10.1182/bloodadvances.2022009253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10206437/
https://www.ncbi.nlm.nih.gov/pubmed/36649566
http://dx.doi.org/10.1182/bloodadvances.2022009253

Ejemplares similares